157 related articles for article (PubMed ID: 11683345)
1. Correlation between the levels of circulating adhesion molecules and PR3-ANCA in Wegener's granulomatosis.
Takizawa M; Maguchi S; Nakamaru Y; Miyatake Y; Fukuda S; Inuyama Y
Auris Nasus Larynx; 2001 May; 28 Suppl():S59-62. PubMed ID: 11683345
[TBL] [Abstract][Full Text] [Related]
2. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis.
Csernok E; Ahlquist D; Ullrich S; Gross WL
Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006
[TBL] [Abstract][Full Text] [Related]
3. Leucocyte membrane expression of proteinase 3 correlates with disease activity in patients with Wegener's granulomatosis.
Muller Kobold AC; Kallenberg CG; Tervaert JW
Br J Rheumatol; 1998 Aug; 37(8):901-7. PubMed ID: 9734683
[TBL] [Abstract][Full Text] [Related]
4. Measurements of proteinase 3 and its complexes with alpha 1-proteinase inhibitor and anti-neutrophil cytoplasm antibodies (ANCA) in plasma.
Baslund B; Petersen J; Permin H; Wiik A; Wieslander J
J Immunol Methods; 1994 Oct; 175(2):215-25. PubMed ID: 7930650
[TBL] [Abstract][Full Text] [Related]
5. Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: epitope analysis using synthetic peptides.
Van Der Geld YM; Simpelaar A; Van Der Zee R; Tervaert JW; Stegeman CA; Limburg PC; Kallenberg CG
Kidney Int; 2001 Jan; 59(1):147-59. PubMed ID: 11135067
[TBL] [Abstract][Full Text] [Related]
6. Interference of PR3-ANCA with the enzymatic activity of PR3: differences in patients during active disease or remission of Wegener's granulomatosis.
van der Geld YM; Tool AT; Videler J; de Haas M; Tervaert JW; Stegeman CA; Limburg PC; Kallenberg CG; Roos D
Clin Exp Immunol; 2002 Sep; 129(3):562-70. PubMed ID: 12197900
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of proteinase 3 by ANCA and its correlation with disease activity in Wegener's granulomatosis.
Daouk GH; Palsson R; Arnaout MA
Kidney Int; 1995 Jun; 47(6):1528-36. PubMed ID: 7643521
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of anti-neutrophil cytoplasmic antibody and pathogenetic role of adhesion molecules for Wegener's granulomatosis].
Takizawa M
Hokkaido Igaku Zasshi; 1996 Jul; 71(4):517-29. PubMed ID: 8809575
[TBL] [Abstract][Full Text] [Related]
9. Circulating soluble adhesion molecules in ANCA-associated vasculitis.
Ara J; Mirapeix E; Arrizabalaga P; Rodriguez R; Ascaso C; Abellana R; Font J; Darnell A
Nephrol Dial Transplant; 2001 Feb; 16(2):276-85. PubMed ID: 11158400
[TBL] [Abstract][Full Text] [Related]
10. ANCA: serology in Wegener's granulomatosis.
Pradhan VD; Badakere SS; Ghosh K; Almeida A
Indian J Med Sci; 2005 Jul; 59(7):292-300. PubMed ID: 16062016
[TBL] [Abstract][Full Text] [Related]
11. Relevance of classic anti-neutrophil cytoplasmic autoantibody (C-ANCA)-mediated inhibition of proteinase 3-alpha 1-antitrypsin complexation to disease activity in Wegener's granulomatosis.
Dolman KM; Stegeman CA; van de Wiel BA; Hack CE; von dem Borne AE; Kallenberg CG; Goldschmeding R
Clin Exp Immunol; 1993 Sep; 93(3):405-10. PubMed ID: 8370167
[TBL] [Abstract][Full Text] [Related]
12. Human anti-neutrophil cytoplasm autoantibodies to proteinase 3 (PR3-ANCA) bind to neutrophils.
Van Rossum AP; van der Geld YM; Limburg PC; Kallenberg CG
Kidney Int; 2005 Aug; 68(2):537-41. PubMed ID: 16014030
[TBL] [Abstract][Full Text] [Related]
13. Interference of Wegener's granulomatosis autoantibodies with neutrophil Proteinase 3 activity.
van de Wiel BA; Dolman KM; van der Meer-Gerritsen CH; Hack CE; von dem Borne AE; Goldschmeding R
Clin Exp Immunol; 1992 Dec; 90(3):409-14. PubMed ID: 1458677
[TBL] [Abstract][Full Text] [Related]
14. T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG).
Brouwer E; Stegeman CA; Huitema MG; Limburg PC; Kallenberg CG
Clin Exp Immunol; 1994 Dec; 98(3):448-53. PubMed ID: 7994909
[TBL] [Abstract][Full Text] [Related]
15. Elevations of neutrophil proteinase 3 in serum of patients with Wegener's granulomatosis and polyarteritis nodosa.
Henshaw TJ; Malone CC; Gabay JE; Williams RC
Arthritis Rheum; 1994 Jan; 37(1):104-12. PubMed ID: 7907475
[TBL] [Abstract][Full Text] [Related]
16. In vitro up-regulation of E-selectin and induction of interleukin-6 in endothelial cells by autoantibodies in Wegener's granulomatosis and microscopic polyangiitis.
Muller Kobold AC; van Wijk RT; Franssen CF; Molema G; Kallenberg CG; Tervaert JW
Clin Exp Rheumatol; 1999; 17(4):433-40. PubMed ID: 10464553
[TBL] [Abstract][Full Text] [Related]
17. Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis.
Russell KA; Fass DN; Specks U
Arthritis Rheum; 2001 Feb; 44(2):463-8. PubMed ID: 11229478
[TBL] [Abstract][Full Text] [Related]
18. Membrane surface proteinase 3 expression and intracytoplasmic immunoglobulin on neutrophils from patients with ANCA-associated vasculitides.
Csernok E; Schmitt WH; Ernst M; Bainton DF; Gross WL
Adv Exp Med Biol; 1993; 336():45-50. PubMed ID: 8296655
[TBL] [Abstract][Full Text] [Related]
19. Image analysis: a novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener's granulomatosis.
Boomsma MM; Damoiseaux JG; Stegeman CA; Kallenberg CG; Patnaik M; Peter JB; Tervaert JW
J Immunol Methods; 2003 Mar; 274(1-2):27-35. PubMed ID: 12609530
[TBL] [Abstract][Full Text] [Related]
20. Glycosylation of proteinase 3 (PR3) is not required for its reactivity with antineutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis.
Finkielman JD; Merkel PA; Schroeder D; Hoffman GS; Spiera R; St Clair EW; Davis JC; McCune WJ; Lears A; Ytterberg SR; Hummel AM; Viss MA; Peikert T; Stone JH; Specks U;
Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S45-52. PubMed ID: 19646346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
